Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
- 10 July 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 9 (5) , 573-582
- https://doi.org/10.1021/bc980002x
Abstract
Nuclease-resistant aptamers identified from randomized nucleic acid libraries represent a novel class of drug candidates. Aptamers are synthesized chemically and therefore can be readily modified with functional groups that modulate their properties. We report here on the preparation, initial characterization, and functional properties of a nuclease-resistant vascular endothelial growth factor (VEGF) aptamer anchored in liposome bilayers through a lipid group on the aptamer. While the high-affinity binding to VEGF is maintained, the plasma residence time of the liposome-anchored aptamer is considerably improved compared with that of the free aptamer. The lipid group attachment and/or liposome anchoring leads to a dramatic improvement in inhibitory activity of the aptamer toward VEGF-induced endothelial cell proliferation in vitro and vascular permeability increase and angiogenesis in vivo.Keywords
This publication has 11 references indexed in Scilit:
- Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factorNature Biotechnology, 1997
- Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in VitroBiochemistry, 1997
- DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.Journal of Clinical Investigation, 1996
- Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular AdhesionJournal of the American Chemical Society, 1996
- Oligonucleotides as Research, Diagnostic, and Therapeutic AgentsJournal of Biological Chemistry, 1995
- DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONSAnnual Review of Biochemistry, 1995
- Endothelial receptor tyrosine kinases involved in angiogenesis.The Journal of cell biology, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.The EMBO Journal, 1991
- Assays for angiogenesis: A reviewPharmacology & Therapeutics, 1991